We are live on ! Find out more
WAAG

Wealth Alliance Advisory Group Portfolio holdings

AUM $691M
1-Year Est. Return 24.37%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+24.37%
3 Year Est. Return
+66.89%
5 Year Est. Return
+84.25%
10 Year Est. Return
AUM
$261M
AUM Growth
+$34.6M
Cap. Flow
+$14.4M
Cap. Flow %
5.49%
Top 10 Hldgs %
52.43%
Holding
184
New
27
Increased
71
Reduced
44
Closed
11

Sector Composition

Rank Sector Weight
1 Energy 10.8%
2 Financials 8.05%
3 Technology 6.04%
4 Healthcare 5.66%
5 Consumer Staples 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHR
151
Braemar Hotels & Resorts
BHR
$148M
$206K 0.08%
50,000
MQY icon
152
BlackRock MuniYield Quality Fund
MQY
$810M
$203K 0.08%
17,539
-14,136
-45% -$160K
PARA
153
DELISTED
Paramount Global Class B
PARA
$182K 0.07%
10,791
+120
+1% +$2.21K
PHYS icon
154
Sprott Physical Gold
PHYS
$14.7B
$142K 0.05%
10,089
POWW icon
155
Outdoor Holding Co
POWW
$257M
$141K 0.05%
81,498
VGM icon
156
Invesco Trust Investment Grade Municipals
VGM
$553M
$119K 0.05%
11,851
-5,485
-32% -$52.5K
BFK
157
DELISTED
BlackRock Municipal Income Trust
BFK
$111K 0.04%
11,000
-27,775
-72% -$270K
MFD
158
DELISTED
Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund
MFD
$105K 0.04%
13,000
JRO
159
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$96.9K 0.04%
+12,412
New +$100K
AUY
160
DELISTED
Yamana Gold, Inc.
AUY
$87.1K 0.03%
15,700
PFN
161
PIMCO Income Strategy Fund II
PFN
$698M
$84.8K 0.03%
12,000
VBIV
162
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$60.3K 0.02%
5,142
-1,291
-20% -$22.8K
GANX icon
163
Gain Therapeutics
GANX
$73.8M
$58.7K 0.02%
18,751
-6,249
-25% -$19.5K
ABSI icon
164
Absci
ABSI
$1.42B
$54.9K 0.02%
+26,120
New +$71.5K
AMRS
165
DELISTED
Amyris Inc.
AMRS
$52.6K 0.02%
+34,350
New +$76.7K
ZVIA icon
166
Zevia
ZVIA
$121M
$49.9K 0.02%
+12,200
New +$50.3K
DERM icon
167
Journey Medical
DERM
$181M
$31K 0.01%
16,124
-5,376
-25% -$10.6K
DNA icon
168
Ginkgo Bioworks
DNA
$608M
$30.6K 0.01%
+452
New +$41.6K
CGTX icon
169
Cognition Therapeutics
CGTX
$86.7M
$29.1K 0.01%
13,874
-4,626
-25% -$9.34K
VVOS icon
170
Vivos Therapeutics
VVOS
$5.97M
$10.6K ﹤0.01%
1,050
-350
-25% -$5.12K
HELP
171
Cybin Inc
HELP
$568M
$9.19K ﹤0.01%
+789
New +$13K
HGEN
172
DELISTED
HUMANIGEN, INC.
HGEN
$2.7K ﹤0.01%
22,500
-7,500
-25% -$1.08K
NAK
173
Northern Dynasty Minerals
NAK
$885M
$2.21K ﹤0.01%
10,000
AQN icon
174
Algonquin Power & Utilities
AQN
$4.43B
-11,290
Closed -$123K
CTSH icon
175
Cognizant
CTSH
$24.6B
-3,821
Closed -$219K

Similar funds

Wealth Alliance Advisory Group's Q4 2022 Portfolio in Review

As of Q4 2022, Wealth Alliance Advisory Group held 184 positions worth $261M, up 15% from $227M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Wealth Alliance Advisory Group deployed $14.4M of net new capital in Q4 2022, opening 27 new positions and adding to 71 existing holdings. Its largest new stake was Franklin Municipal Green Bond ETF: 145,000 shares worth $3.37M.

By sector, the portfolio is most concentrated in Energy at 11% of assets, up from 9.6% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.43M trimmed.

  • Wealth Alliance Advisory Group's largest Q4 2022 buy was Franklin Municipal Green Bond ETF: 145,000 shares worth $3.37M.
  • Wealth Alliance Advisory Group added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $1.48M increase.
  • Wealth Alliance Advisory Group's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.43M.
  • Wealth Alliance Advisory Group fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2022, selling an estimated $759K.
  • Wealth Alliance Advisory Group's ten largest holdings make up 52% of its $261M portfolio in Q4 2022.
  • Wealth Alliance Advisory Group opened 27 new positions and closed 11 in Q4 2022.
  • Wealth Alliance Advisory Group's portfolio value rose 15% quarter-over-quarter to $261M.

Based on Wealth Alliance Advisory Group's 13F filing for Q4 2022, filed 17 Jan 2023.